Bonde J - Search Results

1

Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.

Ejegod DM, Hansen M, Christiansen IK, Pedersen H, Quint W, Xu L, Arbyn M, Bonde J. Ejegod DM, et al. Among authors: bonde j. J Clin Virol. 2020 Jul;128:104336. doi: 10.1016/j.jcv.2020.104336. Epub 2020 May 11. J Clin Virol. 2020. PMID: 32446166

2

Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark.

Goldman B, Rebolj M, Rygaard C, Preisler S, Ejegod DM, Lynge E, Bonde J. Goldman B, et al. Among authors: bonde j. Vaccine. 2013 Mar 15;31(12):1604-9. doi: 10.1016/j.vaccine.2012.12.084. Epub 2013 Jan 10. Vaccine. 2013. PMID: 23313651

3

Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.

Preisler S, Rebolj M, Untermann A, Ejegod DM, Lynge E, Rygaard C, Bonde J. Preisler S, et al. Among authors: bonde j. PLoS One. 2013;8(3):e59765. doi: 10.1371/journal.pone.0059765. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533648 Free PMC article.

4

Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay.

Rebolj M, Preisler S, Ejegod DM, Bonde J, Rygaard C, Lynge E. Rebolj M, et al. Among authors: bonde j. J Mol Diagn. 2013 Sep;15(5):670-7. doi: 10.1016/j.jmoldx.2013.04.002. Epub 2013 Jul 1. J Mol Diagn. 2013. PMID: 23827659 Free article.

5

Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.

Rebolj M, Preisler S, Ejegod DM, Rygaard C, Lynge E, Bonde J. Rebolj M, et al. Among authors: bonde j. PLoS One. 2014 Jan 20;9(1):e86835. doi: 10.1371/journal.pone.0086835. eCollection 2014. PLoS One. 2014. PMID: 24466262 Free PMC article.

6

Cervical cancer screening at crossroads.

Lynge E, Rygaard C, Baillet MV, Dugué PA, Sander BB, Bonde J, Rebolj M. Lynge E, et al. Among authors: bonde j. APMIS. 2014 Aug;122(8):667-73. doi: 10.1111/apm.12279. APMIS. 2014. PMID: 25046198 Review.

7

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.

Bonde J, Rebolj M, Ejegod DM, Preisler S, Lynge E, Rygaard C. Bonde J, et al. BMC Infect Dis. 2014 Jul 26;14:413. doi: 10.1186/1471-2334-14-413. BMC Infect Dis. 2014. PMID: 25064473 Free PMC article.

8

Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology.

Rebolj M, Lynge E, Ejegod D, Preisler S, Rygaard C, Bonde J. Rebolj M, et al. Among authors: bonde j. Gynecol Oncol. 2014 Dec;135(3):474-80. doi: 10.1016/j.ygyno.2014.10.014. Epub 2014 Oct 23. Gynecol Oncol. 2014. PMID: 25449563 Free article.

9

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.

Ejegod DM, Rebolj M, Bonde J. Ejegod DM, et al. Among authors: bonde j. BMC Cancer. 2015 Apr 2;15:216. doi: 10.1186/s12885-015-1223-z. BMC Cancer. 2015. PMID: 25886410 Free PMC article.

10

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.

Bottari F, Sideri M, Gulmini C, Igidbashian S, Tricca A, Casadio C, Carinelli S, Boveri S, Ejegod D, Bonde J, Sandri MT. Bottari F, et al. Among authors: bonde j. J Clin Microbiol. 2015 Jul;53(7):2109-14. doi: 10.1128/JCM.00246-15. Epub 2015 Apr 22. J Clin Microbiol. 2015. PMID: 25903574 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

750 results

Search Page

Filters